Sat 17 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Prospective multi-country, real-world, multi-arm study of treatment PErsistence with RISankizumab in Psoriatic Arthritis | Abbvie/ Ray | Ongoing | Risankizumab | 4 | P24-390 | King Fahad Medical City (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants with Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM) | Eli Lilly / IQVIA | Ongoing | Orforglipron | 3 | J2A-MC-GZPV | King Saud University Medical City (Riyadh), King Fahad Specialist Hospital (Dammam), Imam Abdulrahman Bin Faisal University (Dammam), King Abdulaziz University Hospital (Jeddah), King Fahad Armed Forces Hospital (Jeddah), King Abdulaziz Medical City NG (Al Ahsa ), Fakeeh Medical Center (Jeddah), King Fahad Medical City (Riyadh) |
| PROLONG Study: Non-Interventional, Observational, Retrospective and Prospective, Single-Arm Study to Assess the Effectiveness of Olaparib and Abiraterone Combination as First Line Therapy in NHA pre-exposed mCRPC patients in the GCC region | PI Initiated | Ongoing | Olaparib and Abiraterone | 4 | D0817R0013 | Security Forces Hospital (Riyadh) |
| Spinal Muscular Atrophy Center-based REAL World Retrospective Medical Chart Review of Patient Treated with Onasemnogene Abeparvovec (Zolgensma®) in Saudi Arabia | Novartis/ Ray | Ongoing | Onasemnogene Abeparvovec | 4 | COAV101A1S | King Fahad Specialist Hospital (Dammam) |
| Comparison Between Botox Injections and Trigger Point Injections Efficacy for The Management of Myofascial Pain Syndrome | PI Initiated | Ongoing | Botulinum toxin type A / Lidocaine hydrochloride | 3 | E-24-9413 | King Saud University Dental Center (Riyadh) |
| A Phase 1, Single Center, Randomized, Dose Finding Study, to Evaluate the Safety, Tolerability, and Immunogenicity of a Prophylactic COVID-19 pDNA Vaccine After Multiple Ascending Doses in Healthy Adults | Imam Abdulrahman Bin Faisal University (Dammam) | Ongoing | S.opt.FL pDNA IAUAC | 1 | IAU-1-001-2021 | King Abdulaziz Medical City NG (Riyadh) |
| A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult and Adolescent Participants with Autoimmune Encephalitis | Argenex/ IQIVIA | Ongoing | Efgartigimod | 2 | ARGX-113-22-AIE-2001 | King Saud University Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), Imam Abdulrahman Bin Faisal University (Dammam) |
| A Phase 3 Study to Investigate Velzatinib Compared with Imatinib in Adult Participants with Previously Untreated Metastatic And/Or Unresectable Gastrointestinal Stromal Tumors (GIST) And/Or Unresectable Gastrointestinal Stromal Tumors (GIST) | GlaxoSmithKline Research & Development Limited/ Balsam CR | Ongoing | Velzatinib | 3 | 306293 | King Fahad Specialist Hospital (Dammam) |
| The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis in Gulf Countries: DERMIND-AD | Sanofi | Ongoing | Dupilumab | 4 | OBS18647 | Fakeeh Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz University Hospital (Jeddah), Specialized Medical Center (Riyadh) |
| REal-World Application of Luspatercept in Adults with Transfusion-Dependent beta-Thalassemia in the Middle East (RELATE): A non-interventional retrospective and prospective observational study | Bristol Myers Squibb | Ongoing | luspatercept | 4 | CA056-1107 | 1. Prince mohammed bin fahad hosputal - Qatif 2. King Saud University Medical city - Riyadh 3. Alnoor specialist hospital - Madinah 4. Hereditary Blood Disease Center - Alahsa |
Last update date: 06/10/2026 at 08:14 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.